The anti-inflammatory effect of exercise.

Regular exercise offers protection against all-cause mortality, primarily by protection against cardiovascular disease and Type 2 diabetes mellitus. The latter disorders have been associated with chronic low-grade systemic inflammation reflected by a two- to threefold elevated level of several cytokines. Adipose tissue contributes to the production of TNF-alpha, which is reflected by elevated levels of soluble TNF-alpha receptors, IL-6, IL-1 receptor antagonist, and C-reactive protein. We suggest that TNF-alpha rather than IL-6 is the driver behind insulin resistance and dyslipidemia and that IL-6 is a marker of the metabolic syndrome, rather than a cause. During exercise, IL-6 is produced by muscle fibers via a TNF-independent pathway. IL-6 stimulates the appearance in the circulation of other anti-inflammatory cytokines such as IL-1ra and IL-10 and inhibits the production of the proinflammatory cytokine TNF-alpha. In addition, IL-6 enhances lipid turnover, stimulating lipolysis as well as fat oxidation. We suggest that regular exercise induces suppression of TNF-alpha and thereby offers protection against TNF-alpha-induced insulin resistance. Recently, IL-6 was introduced as the first myokine, defined as a cytokine that is produced and released by contracting skeletal muscle fibers, exerting its effects in other organs of the body. Here we suggest that myokines may be involved in mediating the health-beneficial effects of exercise and that these in particular are involved in the protection against chronic diseases associated with low-grade inflammation such as diabetes and cardiovascular diseases.

[1]  S. Nielsen,et al.  Cachectin/tumor necrosis factor and interleukin-1 show different modes of combined effect on lipoprotein lipase activity and intracellular lipolysis in 3T3-L1 cells. , 1989, Biochimica et biophysica acta.

[2]  B. Saltin,et al.  Interleukin-6 stimulates lipolysis and fat oxidation in humans. , 2003, The Journal of clinical endocrinology and metabolism.

[3]  S. Akira,et al.  IL‐6 and NF‐IL6 in Acute‐Phase Response and Viral Infection , 1992, Immunological reviews.

[4]  L. Abraham,et al.  The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription. , 1997, Molecular immunology.

[5]  A. Steensberg,et al.  Plasma interleukin-6 during strenuous exercise: role of epinephrine. , 2001, American journal of physiology. Cell physiology.

[6]  P. Patterson,et al.  Leukemia Inhibitory Factor, Interleukin 6, and Other Cytokines Using the GP130 Transducing Receptor: Roles in Inflammation and Injury , 1999, Stem cells.

[7]  S. Haffner,et al.  Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. , 2002, Diabetes.

[8]  M. Febbraio,et al.  IL-6 and TNF-α expression in, and release from, contracting human skeletal muscle , 2002 .

[9]  M. Clark,et al.  Acute impairment of insulin-mediated capillary recruitment and glucose uptake in rat skeletal muscle in vivo by TNF-alpha. , 2000, Diabetes.

[10]  L. Abraham,et al.  The −308 tumor necrosis factor-α promoter polymorphism effects transcription , 1997 .

[11]  N. Secher,et al.  Interleukin‐6 release from the human brain during prolonged exercise , 2002, The Journal of physiology.

[12]  A. Steensberg,et al.  Muscle‐derived interleukin‐6: possible biological effects , 2001, The Journal of physiology.

[13]  B. Saltin,et al.  Production of interleukin‐6 in contracting human skeletal muscles can account for the exercise‐induced increase in plasma interleukin‐6 , 2000, The Journal of physiology.

[14]  P. Libby,et al.  Inflammation and Atherosclerosis , 2002, Circulation.

[15]  E. Eldrup,et al.  Circulating levels of TNF-alpha and IL-6-relation to truncal fat mass and muscle mass in healthy elderly individuals and in patients with type-2 diabetes , 2003, Mechanisms of Ageing and Development.

[16]  Bente Klarlund Pedersen,et al.  Exercise and IL‐6 infusion inhibit endotoxin‐induced TNF‐α production in humans , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[17]  J. Davis,et al.  Influence of mode and carbohydrate on the cytokine response to heavy exertion. , 1998, Medicine and science in sports and exercise.

[18]  T. Valle,et al.  The Finnish Diabetes Prevention Study , 2000, British Journal of Nutrition.

[19]  P. Gosling,et al.  Exercise training for intermittent claudication: does it adversely affect biochemical markers of the exercise-induced inflammatory response? , 1997, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[20]  T. van der Poll,et al.  Endocrinologic and metabolic effects of interleukin-6 in humans. , 1995, The American journal of physiology.

[21]  K. Machida,et al.  Exhaustive exercise and type-1/type-2 cytokine balance with special focus on interleukin-12 p40/p70. , 2003, Exercise immunology review.

[22]  L. Ferrucci,et al.  Cardiovascular Disease, Interleukin-6, and Risk of Mortality in Older Women: The Women’s Health and Aging Study , 2001, Circulation.

[23]  N. Secher,et al.  Glucose Ingestion Attenuates Interleukin‐6 Release from Contracting Skeletal Muscle in Humans , 2003, The Journal of physiology.

[24]  M. Febbraio,et al.  Carbohydrate ingestion attenuates the increase in plasma interleukin‐6, but not skeletal muscle interleukin‐6 mRNA, during exercise in humans , 2001, The Journal of physiology.

[25]  P. Whincup,et al.  Physical Activity and Hemostatic and Inflammatory Variables in Elderly Men , 2002, Circulation.

[26]  M. Febbraio,et al.  Acute IL-6 treatment increases fatty acid turnover in elderly humans in vivo and in tissue culture in vitro. , 2005, American journal of physiology. Endocrinology and metabolism.

[27]  K. Feingold,et al.  Interleukin-6 stimulates hepatic triglyceride secretion in rats. , 1995, Endocrinology.

[28]  J. Pankow,et al.  Low-grade systemic inflammation and the development of type 2 diabetes mellitus [ndash] : the ARIC Study , 2003 .

[29]  B. Pedersen,et al.  Prolonged submaximal eccentric exercise is associated with increased levels of plasma IL-6. , 1997, The American journal of physiology.

[30]  K. Ogawa,et al.  Exercise induces recruitment of lymphocytes with an activated phenotype and short telomeres in young and elderly humans. , 1999, Life sciences.

[31]  P. Libby.  Inflammation in atherosclerosis , 2002, Nature.

[32]  B. Pedersen,et al.  The cytokine response to strenuous exercise. , 1998, Canadian journal of physiology and pharmacology.

[33]  Alan D. Lopez,et al.  Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study , 1997, The Lancet.

[34]  S. Coppack.  Pro-inflammatory cytokines and adipose tissue , 2001, Proceedings of the Nutrition Society.

[35]  C. Dinarello.  Interleukin-1 and interleukin-1 antagonism. , 1991, Blood.

[36]  M. Laakso,et al.  Promoter polymorphisms of the TNF-alpha (G-308A) and IL-6 (C-174G) genes predict the conversion from impaired glucose tolerance to type 2 diabetes: the Finnish Diabetes Prevention Study. , 2003, Diabetes.

[37]  M. Billah,et al.  IL-10 inhibits transcription of cytokine genes in human peripheral blood mononuclear cells. , 1994, Journal of immunology.

[38]  C. Marsh,et al.  Acute phase levels of C-reactive protein enhance IL-1 beta and IL-1ra production by human blood monocytes but inhibit IL-1 beta and IL-1ra production by alveolar macrophages. , 1996, Journal of immunology.

[39]  G. Hotamisligil,et al.  Mechanisms of TNF-alpha-induced insulin resistance. , 2009 .

[40]  G. Cline,et al.  Differential effects of interleukin-6 and -10 on skeletal muscle and liver insulin action in vivo. , 2004, Diabetes.

[41]  B. Pedersen,et al.  Exercise normalises overexpression of TNF-alpha in knockout mice. , 2004, Biochemical and biophysical research communications.

[42]  Roy J. Shephard,et al.  Exercise elevates plasma levels but not gene expression of IL-1β, IL-6, and TNF-α in blood mononuclear cells , 2000 .

[43]  Katsuhiko Suzuki,et al.  Circulating cytokines and hormones with immunosuppressive but neutrophil-priming potentials rise after endurance exercise in humans , 2000, European Journal of Applied Physiology.

[44]  C. Dinarello.  The role of the interleukin-1-receptor antagonist in blocking inflammation mediated by interleukin-1. , 2000, The New England journal of medicine.

[45]  E. Schleicher,et al.  Palmitate, but Not Unsaturated Fatty Acids, Induces the Expression of Interleukin-6 in Human Myotubes through Proteasome-dependent Activation of Nuclear Factor-κB* , 2004, Journal of Biological Chemistry.

[46]  A. Brasier,et al.  Tumor necrosis factor increases the rate of lipolysis in primary cultures of adipocytes without altering levels of hormone-sensitive lipase. , 1994, Endocrinology.

[47]  S. Van Uum,et al.  Endurance run increases circulating IL-6 and IL-1ra but downregulates ex vivo TNF-alpha and IL-1 beta production. , 1995, Journal of applied physiology.

[48]  J. M. Lipton,et al.  Cytokine antagonists in aged subjects and their relation with cellular immunity. , 1997, The journals of gerontology. Series A, Biological sciences and medical sciences.

[49]  J. Davis,et al.  Effects of mode and carbohydrate on the granulocyte and monocyte response to intensive, prolonged exercise. , 1998, Journal of applied physiology.

[50]  R. Dobbs,et al.  Association of circulating TNF‐α and IL‐6 with ageing and parkinsonism , 1999 .

[51]  E. Ford.  Leukocyte count, erythrocyte sedimentation rate, and diabetes incidence in a national sample of US adults. , 2002, American journal of epidemiology.

[52]  S. Coppack,et al.  Production of soluble tumor necrosis factor receptors by human subcutaneous adipose tissue in vivo. , 1999, The American journal of physiology.

[53]  M. Netea,et al.  Influence of anti-tumour necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritis , 2004, Annals of the rheumatic diseases.

[54]  C. Tsigos,et al.  Circulating tumor necrosis factor alpha concentrations are higher in abdominal versus peripheral obesity. , 1999, Metabolism: clinical and experimental.

[55]  P. Macfarlane,et al.  The prognostic value of the electrocardiogram in the west of Scotland coronary prevention study , 2002 .

[56]  B. Spiegelman,et al.  Tumor Necrosis Factor (TNF)-α Inhibits Insulin Signaling through Stimulation of the p55 TNF Receptor and Activation of Sphingomyelinase* , 1996, The Journal of Biological Chemistry.

[57]  B. Pedersen,et al.  Supplementation with vitamins C and E inhibits the release of interleukin‐6 from contracting human skeletal muscle , 2004, The Journal of physiology.

[58]  U. Smith,et al.  Interleukin-6 (IL-6) Induces Insulin Resistance in 3T3-L1 Adipocytes and Is, Like IL-8 and Tumor Necrosis Factor-α, Overexpressed in Human Fat Cells from Insulin-resistant Subjects* , 2003, Journal of Biological Chemistry.

[59]  B. Saltin,et al.  Does the aging skeletal muscle maintain its endocrine function? , 2004, Exercise immunology review.

[60]  L. Christiansen,et al.  The IL-6 −174G>C polymorphism is associated with cardiovascular diseases and mortality in 80-year-old humans , 2004, Experimental Gerontology.

[61]  N. Secher,et al.  Lymphocytes and NK cell activity during repeated bouts of maximal exercise. , 1996, The American journal of physiology.

[62]  L. Old,et al.  Tumor necrosis factor (TNF). , 1985, Science.

[63]  Bente Klarlund Pedersen,et al.  Physical activity and plasma interleukin-6 in humans – effect of intensity of exercise , 2000, European Journal of Applied Physiology.

[64]  N. Miyasaka,et al.  Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: a multicenter, double-blind, placebo-controlled trial. , 2004, Arthritis and rheumatism.

[65]  L. Ferrucci,et al.  Cross-sectional and prospective relationships of interleukin-6 and C-reactive protein with physical performance in elderly persons: MacArthur studies of successful aging. , 2000, The journals of gerontology. Series A, Biological sciences and medical sciences.

[66]  S. Ebrahim,et al.  Exercise-based rehabilitation for coronary heart disease. , 2001, The Cochrane database of systematic reviews.

[67]  B. Spiegelman,et al.  IRS-1-Mediated Inhibition of Insulin Receptor Tyrosine Kinase Activity in TNF-α- and Obesity-Induced Insulin Resistance , 1996, Science.

[68]  K. Suzuki,et al.  White blood-cell count and the risk of impaired fasting glucose or Type II diabetes in middle-aged Japanese men , 2002, Diabetologia.

[69]  A. Greenberg,et al.  Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1998 by The Endocrine Society Omental and Subcutaneous Adipose Tissues of Obese Subjects Release Interleukin-6: Depot Difference and Regulation by Glucocorticoid* , 1997 .

[70]  T. van der Poll,et al.  Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin 10 production during human endotoxemia. , 1996, The Journal of clinical investigation.

[71]  B. Pedersen,et al.  Evidence that interleukin‐6 is produced in human skeletal muscle during prolonged running , 1998, The Journal of physiology.

[72]  S. Borst,et al.  Neutralization of tumor necrosis factor reverses age-induced impairment of insulin responsiveness in skeletal muscle of Sprague-Dawley rats. , 2002, Metabolism: clinical and experimental.

[73]  C. Bruce,et al.  Cytokine regulation of skeletal muscle fatty acid metabolism: effect of interleukin-6 and tumor necrosis factor-alpha. , 2004, American journal of physiology. Endocrinology and metabolism.

[74]  H. Langberg,et al.  Substantial elevation of interleukin‐6 concentration in peritendinous tissue, in contrast to muscle, following prolonged exercise in humans , 2002, The Journal of physiology.

[75]  B. Pedersen,et al.  AMPK activity is diminished in tissues of IL-6 knockout mice: the effect of exercise. , 2004, Biochemical and biophysical research communications.

[76]  C. Dinarello.  Interleukin-1 and tumor necrosis factor: effector cytokines in autoimmune diseases. , 1992, Seminars in immunology.

[77]  Ose,et al.  Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events* , 2002 .

[78]  A. Steensberg,et al.  Interleukin-6 production by contracting human skeletal muscle: autocrine regulation by IL-6. , 2003, Biochemical and biophysical research communications.

[79]  B. Pedersen,et al.  N-3 polyunsaturated fatty acids do not affect cytokine response to strenuous exercise. , 2000, Journal of applied physiology.

[80]  E. Newsholme,et al.  Some aspects of the acute phase response after a marathon race, and the effects of glutamine supplementation , 1996, European Journal of Applied Physiology and Occupational Physiology.

[81]  David Carling,et al.  The AMP-activated protein kinase cascade--a unifying system for energy control. , 2004, Trends in biochemical sciences.

[82]  C. Gabay,et al.  Interleukin 1 receptor antagonist (IL-1Ra) is an acute-phase protein. , 1997, The Journal of clinical investigation.

[83]  Y. Lacasse,et al.  Pulmonary rehabilitation for chronic obstructive pulmonary disease. , 2006, The Cochrane database of systematic reviews.

[84]  L Hoffman-Goetz,et al.  Exercise and the immune system: regulation, integration, and adaptation. , 2000, Physiological reviews.

[85]  G. Paolisso,et al.  Advancing age and insulin resistance : role of plasma tumor necrosis factor-a , 1998 .

[86]  J. Bülow,et al.  Interleukin‐6 production in human subcutaneous abdominal adipose tissue: the effect of exercise , 2002, The Journal of physiology.

[87]  Mitchell J. Anderson,et al.  Circulating monocytes are not the source of elevations in plasma IL-6 and TNF-alpha levels after prolonged running. , 2001, American journal of physiology. Cell physiology.

[88]  A. Billiau,et al.  Anti-gamma interferon and anti-interleukin-6 antibodies affect staphylococcal enterotoxin B-induced weight loss, hypoglycemia, and cytokine release in D-galactosamine-sensitized and unsensitized mice , 1995, Infection and immunity.

[89]  B. Spiegelman,et al.  Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. , 1993, Science.

[90]  V. Manganiello,et al.  Tumor necrosis factor-alpha stimulates lipolysis in differentiated human adipocytes through activation of extracellular signal-related kinase and elevation of intracellular cAMP. , 2002, Diabetes.

[91]  B. Saltin,et al.  Interleukin‐6 production in contracting human skeletal muscle is influenced by pre‐exercise muscle glycogen content , 2001, The Journal of physiology.

[92]  M. Pretolani.  Interleukin‐10: an anti‐inflammatory cytokine with therapeutic potential , 1999, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[93]  J. Davis,et al.  Carbohydrate ingestion influences skeletal muscle cytokine mRNA and plasma cytokine levels after a 3-h run. , 2003, Journal of applied physiology.

[94]  E. Sverdlov,et al.  Genes coding for RNA polymerase β subunit in bacteria , 1988 .

[95]  W. Fiers.  Tumor necrosis factor Characterization at the molecular, cellular and in vivo level , 1991, FEBS letters.

[96]  B. Saltin,et al.  Searching for the exercise factor: is IL-6 a candidate? , 2004, Journal of Muscle Research & Cell Motility.

[97]  J. Polak,et al.  Association between physical activity and markers of inflammation in a healthy elderly population. , 2001, American journal of epidemiology.

[98]  K. Fallon,et al.  The acute phase response and exercise: court and field sports , 2001, British journal of sports medicine.

[99]  J. Manson,et al.  C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. , 2001, JAMA.

[100]  P. Schjerling,et al.  Chemokines are elevated in plasma after strenuous exercise in humans , 2001, European Journal of Applied Physiology.

[101]  M. Schroll,et al.  Ageing, tumour necrosis factor‐alpha (TNF‐α) and atherosclerosis , 2000, Clinical and experimental immunology.

[102]  F. Green,et al.  Cooperative Influence of Genetic Polymorphisms on Interleukin 6 Transcriptional Regulation* , 2000, The Journal of Biological Chemistry.

[103]  E. Bruckert,et al.  Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro. , 2002, The Journal of clinical endocrinology and metabolism.

[104]  G. Krishnaswamy,et al.  Long-term exercise and atherogenic activity of blood mononuclear cells in persons at risk of developing ischemic heart disease. , 1999, JAMA.

[105]  J. Mccormack,et al.  Effects of tumor necrosis factor-alpha on insulin action in cultured human muscle cells. , 2001, Diabetes.

[106]  H. Tilg,et al.  IL-6 and APPs: anti-inflammatory and immunosuppressive mediators. , 1997, Immunology today.

[107]  N. Sattar,et al.  Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study. , 2002, Diabetes care.

[108]  R. Sigal,et al.  Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta‐analysis of controlled clinical trials , 2002, JAMA.

[109]  H. Northoff,et al.  The cytokine response to strenuous exercise. , 1994, International journal of sports medicine.

[110]  B. Pedersen,et al.  Exercise normalises overexpression of TNF-α in knockout mice , 2004 .

[111]  R. Dobbs,et al.  Association of circulating TNF-alpha and IL-6 with ageing and parkinsonism. , 1999, Acta neurologica Scandinavica.

[112]  W. Guggino,et al.  Characterization of vectorial chloride transport pathways in the human pancreatic duct adenocarcinoma cell line HPAF. , 2003, American journal of physiology. Cell physiology.

[113]  I. Mertens,et al.  Reduction of the plasma concentration of C-reactive protein following nine months of endurance training. , 2000, International journal of sports medicine.

[114]  B. Pedersen,et al.  A high plasma concentration of TNF-alpha is associated with dementia in centenarians. , 1999, The journals of gerontology. Series A, Biological sciences and medical sciences.

[115]  K. Uysal,et al.  Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. , 1997, Nature.

[116]  M. Kibata,et al.  Relationship between serum tumor necrosis factor-α and insulin resistance in obese men with Type 2 diabetes mellitus , 2001 .

[117]  S. Blair,et al.  Is physical activity or physical fitness more important in defining health benefits? , 2001, Medicine and science in sports and exercise.

[118]  K. Petersen,et al.  Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. , 2004, The New England journal of medicine.

[119]  Y. Hellsten,et al.  Xanthine oxidase in human skeletal muscle following eccentric exercise: a role in inflammation. , 1997, The Journal of physiology.

[120]  Peter Schjerling,et al.  Pro‐ and anti‐inflammatory cytokine balance in strenuous exercise in humans , 1999, The Journal of physiology.

[121]  Jonathan Krakoff,et al.  Adiponectin and development of type 2 diabetes in the Pima Indian population , 2002, The Lancet.

[122]  J. Hokanson,et al.  The Insulin Resistance Atherosclerosis Study Family Study , 2004 .

[123]  B. Pedersen,et al.  A trauma‐like elevation of plasma cytokines in humans in response to treadmill running , 1998, The Journal of physiology.

[124]  P. Ridker,et al.  C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. , 2000, The New England journal of medicine.

[125]  L. Kuller,et al.  The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study. , 2001, Diabetes.

[126]  B. Tian,et al.  Tumor Necrosis Factor α Stimulates Lipolysis in Adipocytes by Decreasing Gi Protein Concentrations* , 1999, The Journal of Biological Chemistry.

[127]  Mutsuo Yamada,et al.  Systemic inflammatory response to exhaustive exercise. Cytokine kinetics. , 2002, Exercise immunology review.

[128]  K. Uysal,et al.  Protection from obesity-induced insulin resistance in mice lacking TNF-α function , 1997, Nature.

[129]  S. Akira,et al.  Interleukin-6 in biology and medicine. , 1993, Advances in immunology.

[130]  J V Castell,et al.  Plasma clearance, organ distribution and target cells of interleukin-6/hepatocyte-stimulating factor in the rat. , 1988, European journal of biochemistry.

[131]  J. Davis,et al.  Carbohydrate and the cytokine response to 2.5 h of running. , 1997, Journal of applied physiology.

[132]  Roy Taylor,et al.  Effects of Tumor Necrosis Factor-α on Insulin Action in Cultured Human Muscle Cells , 2001 .

[133]  M. Piepoli,et al.  Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH) , 2004, BMJ : British Medical Journal.

[134]  P. Ridker,et al.  Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. , 2000, Circulation.

[135]  M. Febbraio,et al.  Acute interleukin‐6 administration does not impair muscle glucose uptake or whole‐body glucose disposal in healthy humans , 2003, The Journal of physiology.

[136]  A. Steensberg,et al.  IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans. , 2003, American journal of physiology. Endocrinology and metabolism.

[137]  M. Kibata,et al.  Relationship between serum tumor necrosis factor-alpha and insulin resistance in obese men with Type 2 diabetes mellitus. , 2001, Diabetes research and clinical practice.

[138]  A. Aljada,et al.  Inflammation: the link between insulin resistance, obesity and diabetes. , 2004, Trends in immunology.

[139]  M. Schroll,et al.  Predicting death from tumour necrosis factor‐alpha and interleukin‐6 in 80‐year‐old people , 2003, Clinical and experimental immunology.

[140]  M. Piepoli,et al.  Exercise training in patients with chronic heart failure , 2004, BMJ : British Medical Journal.

[141]  D. Yach,et al.  The global burden of chronic diseases: overcoming impediments to prevention and control. , 2004, JAMA.

[142]  S. Souza,et al.  BRL 49653 blocks the lipolytic actions of tumor necrosis factor-alpha: a potential new insulin-sensitizing mechanism for thiazolidinediones. , 1998, Diabetes.

[143]  M. Febbraio,et al.  Interleukin-6 is a novel factor mediating glucose homeostasis during skeletal muscle contraction. , 2004, Diabetes.

[144]  G. Paolisso,et al.  Advancing age and insulin resistance: role of plasma tumor necrosis factor-alpha. , 1998, The American journal of physiology.

[145]  D. Salamon,et al.  Elevated serum tumor necrosis factor-alpha concentrations and bioactivity in Type 2 diabetics and patients with android type obesity. , 1998, Diabetes research and clinical practice.

[146]  R. Ross,et al.  Hyperlipidemia and atherosclerosis. , 1976, Science.

[147]  H. Mcdevitt,et al.  Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[148]  K. Feingold,et al.  Role of Cytokines in Inducing Hyperlipidemia , 1992, Diabetes.

[149]  R. Ross.  Atherosclerosis is an inflammatory disease , 1999 .

[150]  P. Neufer,et al.  Transcriptional activation of the IL‐6 gene in human contracting skeletal muscle: influence of muscle glycogen content , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[151]  L. Mion,et al.  Quantitative and qualitative alterations of acute-phase proteins in healthy elderly persons. , 1996, Age and ageing.

[152]  L. G. Moss,et al.  Overexpression of Perilipin A and B Blocks the Ability of Tumor Necrosis Factor α to Increase Lipolysis in 3T3-L1 Adipocytes* , 1998, The Journal of Biological Chemistry.

[153]  M. Febbraio,et al.  Muscle‐derived interleukin‐6: mechanisms for activation and possible biological roles , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[154]  M. Billah,et al.  Interleukin-10 inhibits interleukin-8 production in human neutrophils. , 1994, Blood.

[155]  A. Brasier,et al.  Inhibition of Proteasome Activity Blocks the Ability of TNFα to Down-Regulate Gi Proteins and Stimulate Lipolysis. , 2001, Endocrinology.

[156]  Mitchell J. Anderson,et al.  Interleukin-6 and tumor necrosis factor-α are not increased in patients with Type 2 diabetes: evidence that plasma interleukin-6 is related to fat mass and not insulin responsiveness , 2004, Diabetologia.

[157]  M. Febbraio,et al.  Skeletal myocytes are a source of interleukin‐6 mRNA expression and protein release during contraction: evidence of fiber type specificity , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[158]  P. Savage,et al.  Carrying the burden of cardiovascular risk in old age: associations of weight and weight change with prevalent cardiovascular disease, risk factors, and health status in the Cardiovascular Health Study. , 1997, The American journal of clinical nutrition.

[159]  A. Mainous,et al.  Inflammatory markers and exercise: differences related to exercise type. , 2003, Medicine and science in sports and exercise.

[160]  V. Vaccarino,et al.  Relationship between physical activity and inflammation among apparently healthy middle-aged and older US adults. , 2002, Archives of internal medicine.

[161]  W. Scherbaum,et al.  Human breast adipocytes express interleukin-6 (IL-6) and its receptor system: increased IL-6 production by beta-adrenergic activation and effects of IL-6 on adipocyte function. , 2001, The Journal of clinical endocrinology and metabolism.

[162]  F. Lönnqvist,et al.  Mapping of Early Signaling Events in Tumor Necrosis Factor-α-mediated Lipolysis in Human Fat Cells* , 2002, The Journal of Biological Chemistry.

[163]  C. Dinarello,et al.  Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF. , 1990, Blood.

[164]  I. Vauhkonen,et al.  The C-174G promoter polymorphism of the IL-6 gene affects energy expenditure and insulin sensitivity. , 2003, Diabetes.

[165]  B. Pedersen,et al.  Muscle contractions induce interleukin‐6 mRNA production in rat skeletal muscles , 2000, The Journal of physiology.

[166]  D. Papanicolaou,et al.  Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. , 2000, The Journal of clinical endocrinology and metabolism.

[167]  R. Henry,et al.  The expression of TNF alpha by human muscle. Relationship to insulin resistance. , 1996, The Journal of clinical investigation.

[168]  J. Mei,et al.  Down-regulation of cyclic-nucleotide phosphodiesterase 3B in 3T3-L1 adipocytes induced by tumour necrosis factor alpha and cAMP. , 2000, The Biochemical journal.

[169]  E. O’Neill,et al.  T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6 , 1994, The Journal of experimental medicine.

[170]  H. Ullum,et al.  Bicycle exercise enhances plasma IL-6 but does not change IL-1 alpha, IL-1 beta, IL-6, or TNF-alpha pre-mRNA in BMNC. , 1994, Journal of applied physiology.

[171]  N. Sattar,et al.  C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. , 2002, Diabetes.

[172]  Christian Weyer,et al.  High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes. , 2002, Diabetes.

[173]  B. Pedersen,et al.  Immunohistochemical detection of interleukin‐6 in human skeletal muscle fibers following exercise , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[174]  Y. Vodovotz,et al.  Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-beta and interleukin-10. , 1992, The Journal of biological chemistry.